Topical and Intralesional Treatment of Nonmelanoma Skin Cancer: Efficacy and Cost Comparisons

@article{Chitwood2013TopicalAI,
  title={Topical and Intralesional Treatment of Nonmelanoma Skin Cancer: Efficacy and Cost Comparisons},
  author={Katelyn Chitwood and J. Etzkorn and G. Cohen},
  journal={Dermatologic Surgery},
  year={2013},
  volume={39},
  pages={1306–1316}
}
  • Katelyn Chitwood, J. Etzkorn, G. Cohen
  • Published 2013
  • Medicine
  • Dermatologic Surgery
  • Background Topical chemotherapy, topical immunomodulators, or intralesional chemotherapy may be used to treat nonmelanoma skin cancer (NMSC). Objectives To review the cost and efficacy of topical and intralesional therapies for NMSC. Methods Literature search assessing the efficacy of NMSC treatment with topical imiquimod, topical 5‐flourouracil (5FU) intralesional 5FU, methotrexate, bleomycin, and interferon (IFN). Single‐lesion case reports were excluded. Aggregate cure rates and the… CONTINUE READING
    Intralesional therapy for the treatment of keratoacanthoma
    • 4

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 76 REFERENCES
    Intralesional chemotherapy for nonmelanoma skin cancer: a practical review.
    • 62